Teva Targets Ex-Exec Who Dated, Gave Info To Apotex CEO

Law360, New York (July 7, 2017, 6:11 PM EDT) -- Apotex Inc. is profiting off trade secrets the CEO’s girlfriend, an executive at Teva Pharmaceutical USA Inc., provided to him about product development, Teva told a Pennsylvania federal court Friday.

Barinder Sandhu, Teva’s former senior director of regulatory affairs for U.S. generics, allegedly provided confidential information to Apotex CEO Jeremy Desai, with whom she was in a romantic relationship. Apotex used that information to develop its own product strategy and response, an unfair move, Teva said.

"Sandhu was a trusted Teva USA employee, who gave Teva...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

TEVA PHARMACEUTICALS USA, INC. v. SANDHU et al


Case Number

2:17-cv-03031

Court

Pennsylvania Eastern

Nature of Suit

890(Other Statutes: Other Statutory Actions)

Judge

HONORABLE THOMAS N. ONEILL, JR

Date Filed

July 7, 2017

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.